icrf 193 has been researched along with methylformamide in 1 studies
Studies (icrf 193) | Trials (icrf 193) | Recent Studies (post-2010) (icrf 193) | Studies (methylformamide) | Trials (methylformamide) | Recent Studies (post-2010) (methylformamide) |
---|---|---|---|---|---|
155 | 0 | 30 | 275 | 7 | 32 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beere, HM; Chresta, CM; Hickman, JA | 1 |
1 other study(ies) available for icrf 193 and methylformamide
Article | Year |
---|---|
Selective inhibition of topoisomerase II by ICRF-193 does not support a role for topoisomerase II activity in the fragmentation of chromatin during apoptosis of human leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Diketopiperazines; DNA Damage; Enzyme Inhibitors; Etoposide; Formamides; HL-60 Cells; Humans; Piperazines; Topoisomerase II Inhibitors | 1996 |